An interesting potential treatment? I am not quite so sure how practical this would be, but the results are interesting.
…”adoptive cellular therapy using donor-derived virus-specific T cells. Here we show that SARS-CoV-2-exposed blood donations contain CD4 and CD8 memory T cells specific for SARS-CoV-2 spike, nucleocapsid and membrane antigens…… These T cells can be rapidly expanded using GMP-compliant reagents for use as a therapeutic product. ” .,Read More
Highlights • Life cycle of SARS-CoV-2 in host cell have been demonstrated. • CT scan and RT-PCR are very helpful in diagnosis of COVID-19 infection. • Antiviral, antimalarial, antimicrobial and ROCK inhibitors were found very effective. • Dietary supplements […]
Dustin Chambers for The New York Times Researchers have long known that masks can prevent people from spreading airway germs to others — findings that have driven much of the conversation around these crucial accessories during the coronavirus pandemic. […]
Click here to view original web page at Masks May Reduce Viral Dose, Some Experts Say
The first large phase 3 trial of a candidate coronavirus vaccine in the U.S. began today (July 27). The biotech company Moderna is conducting the phase 3 trial, called COVE (Coronavirus Efficacy), in collaboration with the National Institute of […]
Click here to view original web page at Late-stage coronavirus vaccine trial starts today in the US
Abstract We analyzed the bacterial communities of the nasopharynx in 40 SARS-CoV-2 infected and uninfected patients. All infected patients had a mild COVID-19 disease. We did not find statistically significant differences in either bacterial richness and diversity or composition. […]
Spike glycoprotein, a class I fusion protein harboring the surface of SARS-CoV-2 (SARS-CoV-2S), plays a seminal role in the viral infection starting from recognition of the host cell surface receptor, attachment to the fusion of the viral envelope with […]
